Indo Us Bio-Tech Profile
Key Indicators
- Authorised Capital ₹ 21.00 Cr
- Paid Up Capital ₹ 20.05 Cr
- Company Age 21 Year, 4 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.56 Cr
- Satisfied Charges ₹ 17.46 Cr
- Revenue Growth 22.95%
- Profit Growth 38.25%
- Ebitda 35.49%
- Net Worth 40.17%
- Total Assets 25.00%
About Indo Us Bio-Tech
Indo Us Bio-Tech Limited (IUBL) is a leading Public Limited Indian Non-Government Company incorporated in India on 04 February 2004 and has a history of 21 years. Its registered office is in Ahmedabad, Gujarat, India.
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 541304.
The Corporate was formerly known as Pollucid Bio-Tech Private Limited. The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 21.00 Cr and a paid-up capital of Rs 20.05 Cr.
The company currently has active open charges totaling ₹3.56 Cr. The company has closed loans amounting to ₹17.46 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Indo Us Bio-Tech Limited India are Rinku Jethva as CFO and Joshi Divyangbhai as Company Secretary. Jagdishkumar Ajudiya, Malti Ajudia, Priyanka Ajudia, and Three other members serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
L01122GJ2004PLC043550
-
Company No.
043550
-
Stock Symbol
BSE : 541304
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
04 Feb 2004
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Listed
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Indo Us Bio-Tech?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jagdishkumar Ajudiya
|
Managing Director | 04-Feb-2004 | Current |
|
Rinku Jethva
|
CFO | 08-Jan-2018 | Current |
|
Joshi Divyangbhai
|
Company Secretary | 24-Jan-2020 | Current |
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Malti Ajudia
|
Whole-Time Director | 01-Nov-2008 | Current |
|
Priyanka Ajudia
|
Director | 23-Nov-2017 | Current |
|
Ritaben Kikani
|
Director | 01-Mar-2019 | Current |
|
Shilpa Thumar
|
Director | 05-Aug-2021 | Current |
|
Nehaben Patel
|
Director | 05-Aug-2021 | Current |
Financial Performance of Indo Us Bio-Tech.
Indo Us Bio-Tech Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 22.95% increase. The company also saw a substantial improvement in profitability, with a 38.25% increase in profit. The company's net worth Soared by an impressive increase of 40.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Indo Us Bio-Tech?
In 2022, Indo Us Bio-Tech had a promoter holding of 74.02% and a public holding of 25.98%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Agripari E-Commerce Private LimitedJagdishkumar Ajudiya and Priyanka Ajudia are mutual person
-
Indo Us Organic Agri Private LimitedJagdishkumar Ajudiya, Malti Ajudia and 1 more are mutual person
-
Indo-Us Agriseeds Limited
Jagdishkumar Ajudiya, Malti Ajudia and 1 more are mutual person
-
Kavyansh Pack Llp
Ritaben Kikani is a mutual person
-
Craft Finechem Llp
Nehaben Patel is a mutual person
Charges (Loans)
₹3.56 Cr
₹17.46 Cr
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 3.45 Cr
- Others : 0.11 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Apr 2023 | Axis Bank Limited | ₹2.00 Cr | Open |
| 20 Sep 2022 | Axis Bank Limited | ₹1.45 Cr | Open |
| 16 Jun 2022 | Others | ₹1.05 M | Open |
| 09 Nov 2019 | Others | ₹11.41 Cr | Satisfied |
| 21 Feb 2012 | Dena Bank | ₹4.75 Cr | Satisfied |
How Many Employees Work at Indo Us Bio-Tech?
Indo Us Bio-Tech has a workforce of 29 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Indo Us Bio-Tech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indo Us Bio-Tech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
